Molecular glue could pave the way for new generation of drugs

A breakthrough class of molecular glue identified at the University of Dundee could pave the way for a new generation of drugs to target cancers and neurodegenerative diseases.

G1 Therapeutics and Pepper Bio Announce Ink Global License Agreement for Lerociclib

What You Should Know: – G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development

April 30, 2024

Therapeutic targets that impact both cardiac and cerebral functions in CNS neurological disorders

Recent advancements highlight the intricate interplay between the heart and brain, underscoring their profound influence on each other, especially concerning central nervous system (CNS) neurological

August 7, 2024

USDA grant awarded to MU researchers to reduce opioid overdoses and suicides in Rural Missouri

Childhood trauma is a key risk factor for future substance use disorder, overdose, and suicide. This is particularly problematic in rural areas where children experience

October 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.